Delivery Order SPE2DB24D2013-SPE2DB25FCJJC
Award Date 6/6/25
Potential Completion Date 6/30/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,408.90 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price contract, awarded on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside, competitively awarded procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Bosulif is a prescription oncology...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Bosulif 400 mg tablets (30-count packages) valued at $11,815.63. The contract is not set-aside and represents a competitively awarded order with an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $11,815.63 and completion deadline of August 29, 2025. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $70,893.78 to AmerisourceBergen Drug Corp for 30-tablet supplies of Bosulif 400 mg, a pharmaceutical product used in oncology treatment. This non-competitive, firm fixed-price delivery order was awarded on September 4, 2025, with a completion date of September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child purchase order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Bosulif 100 mg tablets (120-count units) with a contract ceiling value of $11,408.90. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,704.45 on July 2, 2025, for the supply of Bosulif 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract, which is non-set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Bosulif 400 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $23,631.26 and an ultimate completion date of August 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a $11,815.63 delivery order to AmerisourceBergen Drug Corp for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract type. The delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply transaction. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5.7 million to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a pharmaceutical product used in cancer treatment. This firm fixed price, non-set-aside delivery order was awarded on May 12, 2025, with completion expected by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as a child contract...
- The Defense Logistics Agency awarded a $23,631.26 delivery order to AmerisourceBergen Drug Corp for 30-count packages of Bosulif 400 mg tablets, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Bosulif (bosutinib) is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia, reflecting the Defense...